Determining a particular course of neurodegenerative diseases can be an extremely difficult diagnostic moment, because, despite the universal set of symptoms and features, each patient is surprising in his own way. Therefore, a joint team of medical specialists from the University of Newcastle and Cambridge University decided to create a new type of diagnostic test that could most accurately predict the consequences and physiological characteristics of the deployment of Parkinson's disease, individually for each individual patient.
To carry out such a complex and at the same time promising test, the team of specialists set out with the help of special biomarker systematics, by which they will determine the further course of neurodegeneration. They took 250 patients from several UK hospitals, 150 of which were recently diagnosed with Parkinson's disease. Having taken their blood for analysis, the experts hoped to find somehow convincing and statistically correct biomarkers that could point to certain paths of development of this disease – and such biomarkers were found.
First of all, experts noted that the number and degree of population of aging cells and inflammation is directly related to the intensity of symptoms of neurodegeneration as such – so experts took these indicated aging cells, which have already lost the ability to reproduce themselves, as a basis. Having identified this correlation, they noted that Parkinson's disease became even clearer in its unique and unusual developmental process.
Of course, the diagnostic test itself has not yet fully completed the preliminary stage of testing and is currently continuing to be finalized in the laboratory – however, the successes that have been achieved by the team of specialists in fact promise its quick commercial release. Provided that all subsequent, more complex tests, the experimental type of testing for biomarkers will be successful, and this remains to be guessed.